CTLA4 and lung carcinoma: Three years later, the biodistribution of [64Cu]Cu-DOTA-ipilimumab in mice bearing lung cancer CTLA-4-expressing tumor xenografts was evaluated, demonstrating how the tumor-tracer uptake in vivo could correlate with the CTLA-4 expression in tumor cells.